VantAI
Operations · New York, United States
About VantAI:
VantAI is building a computational pipeline combining state-of-the-art physics-based modeling and machine learning to revolutionize drug discovery and development. Working together with some of the world’s leading biopharmaceutical companies, we design, test, and optimize novel therapies to treat some of the world’s most difficult diseases.
Job Brief:
We are seeking a highly motivated and experienced Senior Project Manager to oversee our collaboration projects with our biopharmaceutical partners, as well as internal R&D pipelines.
As Senior Project Manager, you will be strongly hands-on and involved in day-to-day operations, as well as responsible for maintaining control of diverse and scientifically complex business operations. We expect you to be an experienced and efficient leader with sufficient experience in the technology and life sciences domains. This position will require you to have excellent people skills, business acumen, and an exemplary work ethic, but most importantly, you must be capable of helping functional leaders prioritize across many competing initiatives and projects.
The goals of this position are to maximize the speed and quality with which VantAI develops novel and innovative medicines, to keep client projects on track, and to ensure extensive and sustainable growth towards company milestones.
Key Responsibilities:
Requirements:
Salary: $140,000 - $185,000
This band is a reflection of the job description as written. Looking for a higher salary? Apply anyway! We are happy to speak to more experienced candidates who may require a higher salary and discuss that experience in our first touchpoint.
This job is not in any teams
VantAI
1 followers
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods.